n.broberg
TL2 Moderator · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 2 February 2025 · last posted 3h
75 posts, newest first. Showing up to 150.
-
Request: tag synonyms surfaced in search Replied, post #28 · Meta › Feature requests · 28 Jul 2026 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #118 · Compounds › Semaglutide · 23 Jul 2026 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #59 · Practice › Interactions · 23 Jul 2026 · 0 likes post #58 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Pooling trials with different estimands Replied, post #112 · Evidence › Meta-analyses · 20 Jul 2026 · 14 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
About the Reconstitution category Replied, post #3 · Practice › Reconstitution · 18 Jul 2026 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #82 · Analytics › Impurities & related substances · 16 Jul 2026 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #101 · Compounds › Semaglutide · 15 Jul 2026 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #24 · Start Here › How to Ask · 14 Jul 2026 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #32 · Practice › Reconstitution · 13 Jul 2026 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #41 · Pharmacology › Receptor biology · 11 Jul 2026 · 0 likes On post #37 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #23 · Clinical › Prescriber conversations · 10 Jul 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea…
-
Does a peptide degrade silently, with no visual change? Replied, post #51 · Practice › Storage & stability · 19 Jun 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #41 · Compounds › Tirzepatide · 17 Jun 2026 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #67 · Research Methods › N-of-1 designs · 10 May 2026 · 0 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #89 · Devices › Syringes & needles · 5 May 2026 · 10 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #8 · Evidence › Journal club · 3 May 2026 · 3 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
The best-written scientific paper you have read Replied, post #25 · Lounge › Off topic · 30 Apr 2026 · 10 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #4 · Compounds › Secretagogues & GH axis · 28 Apr 2026 · 3 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #15 · Clinical › Comorbidities · 10 Apr 2026 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Follow-up: State-level differences that actually matter Replied, post #77 · Regional › North America · 8 Apr 2026 · 0 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Constipation management, with a dietitian's contribution Replied, post #45 · Practice › Side effects · 27 Mar 2026 · 1 like Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #51 · Compounds › Tirzepatide · 20 Mar 2026 · 28 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #17 · Sourcing › Logistics · 14 Mar 2026 · 1 like Picking up post #14: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Started this topic · Sourcing › Red flags · 12 Mar 2026 · 1 like When a red flag was a misunderstanding, and the retraction I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #95 · Clinical › Bloodwork · 8 Mar 2026 · 24 likes Worth separating two things that post #91 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #31 · Practice › Reconstitution · 4 Mar 2026 · 25 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Contributing data without breaching anyone's privacy Replied, post #24 · Data & Tools › Datasets · 4 Mar 2026 · 27 likes Picking up post #21: that is the part I would want checked first. Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #31 · Analytics › Impurities & related substances · 24 Feb 2026 · 5 likes On post #27 — agreed on the reasoning, with one qualification. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #130 · Sourcing › Independent verification · 20 Feb 2026 · 0 likes Coming back to post #128, because the follow-up matters more than the original answer. Repeat testing: if you want to verify the same lot a second time, testing with a…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #53 · Practice › Dosing & titration · 17 Feb 2026 · 1 like Picking up post #50: that is the part I would want checked first. How the published trials escalated: they used specific step sizes and intervals. The STEP programme…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #57 · Analytics › Mass spectrometry · 13 Feb 2026 · 17 likes Picking up post #54: that is the part I would want checked first. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it…
-
Preprint servers and what screening they do Replied, post #51 · Evidence › Preprints · 10 Feb 2026 · 13 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #62 · Documentation › Wiki requests · 30 Jan 2026 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #13 · Access › International · 16 Jan 2026 · 7 likes I read post #11 twice before replying, because I had assumed the opposite. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #11 · Outcomes › Body composition · 8 Jan 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #98 · Analytics › Home & field testing · 5 Jan 2026 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #31 · Pharmacology › Receptor biology · 28 Dec 2025 · 22 likes On post #27 — agreed on the reasoning, with one qualification. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #92 · Practice › Reconstitution · 8 Dec 2025 · 12 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #8 · Practice › Reconstitution · 22 Nov 2025 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Prescription requirements and telehealth models Replied, post #25 · Sourcing › Regulatory · 22 Nov 2025 · 3 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #125 · Start Here › How to Ask · 21 Nov 2025 · 12 likes This follows post #122 rather than contradicting it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Follow-up: Why appetite effects are mostly central Replied, post #72 · Pharmacology › Receptor biology · 20 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #96 · Practice › Side effects · 26 Sep 2025 · 22 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Why the timeline is on the right and not the left Replied, post #72 · Meta › Site feedback · 22 Sep 2025 · 0 likes post #71 answers the question as asked. The question underneath it is different. Feature requests: if the site would work better with a feature it does not have (better…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #108 · Compounds › Repair & healing peptides · 19 Aug 2025 · 27 likes I read post #106 twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #8 · Analytics › Method validation · 19 Aug 2025 · 0 likes Worth separating two things that post #4 runs together. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH,…
-
Specification in the result column: why that is a meaningful error Replied, post #20 · Analytics › COA interpretation · 18 Jul 2025 · 14 likes This follows post #17 rather than contradicting it. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
-
Sodium, potassium and magnesium when intake drops Replied, post #64 · Nutrition & Training › Hydration & electrolytes · 18 Jul 2025 · 26 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Coming back to: When "no data" is the complete and final answer Replied, post #30 · Compounds › Other compounds · 1 Jul 2025 · 2 likes post #29 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #71 · Outcomes › Progress reports · 26 Jun 2025 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #8 · Devices › Pens & autoinjectors · 25 Jun 2025 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Sequence verification for an obscure compound: how it is done Replied, post #60 · Compounds › Other compounds · 12 Jun 2025 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #95 · Devices › Cold chain · 1 May 2025 · 0 likes Picking up post #92: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
When "no data" is the complete and final answer Replied, post #161 · Compounds › Other compounds · 27 Apr 2025 · 1 like Worth separating two things that post #157 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #3 · Compounds › Retatrutide · 17 Apr 2025 · 21 likes post #2 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Retatrutide dose escalation in the published trials Replied, post #73 · Compounds › Retatrutide · 1 Apr 2025 · 10 likes Coming back to post #71, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Coverage for the indication versus for the drug Replied, post #13 · Access › Insurance & coverage · 29 Mar 2025 · 4 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #94 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Worth separating two things that post #90 runs together. Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a…
-
Reading order for a first week here, and what to skip until later Replied, post #37 · Start Here › Welcome · 15 Mar 2025 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Domestic fridge temperature mapping: a cheap experiment Started this topic · Devices › Cold chain · 1 Mar 2025 · 50 likes Domestic fridge temperature mapping: a cheap experiment Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #13 · Access › Pricing · 19 Feb 2025 · 11 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
Why mass spectrometry cannot tell you about an epimer Replied, post #41 · Analytics › Mass spectrometry · 29 Jan 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #18 · Analytics › COA interpretation · 17 Jan 2025 · 1 like On post #14 — agreed on the reasoning, with one qualification. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
Recovery when intake is low: what to cut first Replied, post #82 · Nutrition & Training › Resistance training · 14 Jan 2025 · 26 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Oxidation pathways for methionine and tryptophan Replied, post #21 · Analytics › Impurities & related substances · 27 Dec 2024 · 10 likes Picking up post #18: that is the part I would want checked first. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #52 · Compounds › Semaglutide · 22 Dec 2024 · 6 likes Picking up post #49: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #21 · Compounds › Repair & healing peptides · 20 Dec 2024 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Reading a supplementary appendix and finding the interesting part Replied, post #25 · Evidence › Trials · 17 Nov 2024 · 1 like I read post #23 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
The topic list is dense — is that deliberate? Replied, post #48 · Meta › Site feedback · 5 Nov 2024 · 20 likes I read post #46 twice before replying, because I had assumed the opposite. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #65 · Clinical › Prescriber conversations · 26 Sep 2024 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #11 · Compounds › Oral incretins · 27 Aug 2024 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #6 · marked as the solution · Analytics › Method validation · 11 Aug 2024 · 7 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #43 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Journal club: FLOW and the renal composite, component by component Replied, post #9 · Evidence › Journal club · 8 Jul 2024 · 29 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Assessing a warm arrival: the decision process — one year on Replied, post #100 · Sourcing › Logistics · 1 Jun 2024 · 9 likes On post #96 — agreed on the reasoning, with one qualification. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns…